Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Feasibility Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome: A Pilot Study

NCT01089621 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT01089621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01089621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Feasibility Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome: A Pilot Study
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Withdrawn
Start date
March 31, 2010
Completion date
August 31, 2010
Enrollment
0 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia